Direxion mRNA ETF (MSGR)
AMEX: MSGR
· Real-Time Price · USD
13.91
0.10 (0.73%)
At close: Apr 21, 2023, 4:41 PM
0.73% (1D)
| Bid | - |
| Market Cap | 0 |
| AUM | 3.13M |
| NAV | n/a |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 0 |
| Inception Date | Dec 9, 2021 |
| Ask | - |
| Volume | 652 |
| Open | 13.81 |
| Previous Close | 13.81 |
| Day's Range | 13.81 - 13.91 |
| 52-Week Range | 13.81 - 4621.65 |
| Holdings | 24 |
| Expense Ratio | n/a |
About MSGR
The fund, under normal circumstances, invests at least 80% of its assets in the securities that comprise the index or investments with economic characteristics similar to the securities included in the index. The index provides exposure to the performance of companies, publicly listed in the United States, Canada and Europe, that are leading the development and application of messenger RNA (“mRNA”) technology. The fund is non-diversified.
Asset Class Equity
Ticker Symbol MSGR
Inception Date Dec 9, 2021
Provider undefined
Website Fund Home Page
Exchange AMEX
Top Sectors
| Sector | Weight % |
|---|---|
| Technology | 27.40% |
| Industrials | 22.75% |
| Healthcare | 18.64% |
| Consumer Cyclical | 7.45% |
| Consumer Defensive | 5.80% |
Top 10 Holdings 64.22% of assets
| Name | Symbol | Weight |
|---|---|---|
| Vertex Pharmaceutica... | VRTX | 8.09% |
| Beigene, Ltd. | BGNE | 7.51% |
| Arcturus Therapeutic... | ARCT | 7.45% |
| Scilex Holding Compa... | SCLX | 6.82% |
| Alnylam Pharmaceutic... | ALNY | 6.45% |
| Ptc Therapeutics, In... | PTCT | 6.31% |
| Biontech Se | BNTX | 5.76% |
| Moderna, Inc. | MRNA | 5.60% |
| Sarepta Therapeutics... | SRPT | 5.30% |
| Maravai Lifesciences... | MRVI | 4.93% |
